The approved annual report has been sent out for public comment and to be adopted by the Municipal Public Accounts Committee (MPAC) once the public comment period has been concluded ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host its 2025 Annual Meeting ...

Continued growth and solid EBITDA margin Columbus' revenue amounted to DKK 1,659m in 2024, corresponding to an increase of 8%. Organically ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

Inside Information Company Announcement No. 4 - 2025 Aalborg, March 6, 2025 2024 Financial Highlights Revenue grew 54% from mDKK 40.5 in 2023 to mDKK 62.4. (Guidance mDKK 58 - 63). EBITDA ...

Kansans are vital in ensuring accurate National Weather Service warnings during severe weather. Whether it's tornadoes, high ...

LexinFintech's recent profit spike is driven by changes in financial guarantee derivatives, while operating costs outpace ...

Begin by sharing or revisiting your company’s sustainability goals and commitments. Highlight if there have been any updates ...

Q4 2024 Results Conference Call March 12, 2025 5:00 PM ETCompany ParticipantsJenny Mitchell - VP, Finance Strategy and ...

FFO, as adjusted was $600.8 million for the year ended December 31, 2024 compared with $609.4 million for the year ended December 31, 2023. FFO, as adjusted, per diluted share decreased 1.9% to $2.63 ...

The Carson City Cultural Commission is meeting Monday to elect chair and vice chair of the commission and to review ...